Kisspeptin signalling is indispensable for fertility, stimulating gonadotropin-releasing hormone (GnRH) 29 secretion and mediating gonadal steroid feedback on GnRH neurons. Moreover, kisspeptin neurons have 30 been implicated in other non-reproductive neuroendocrine roles. Kisspeptin appears to also regulate 31 growth hormone secretion but much of the data appear contradictory. We sought to clarify a potential role 32 of kisspeptin in GH regulation by examining the effect of kisspeptin antagonists on growth hormone (GH) 33 secretion in ewes under various physiological conditions. Our data show clear and robust increases in GH 34 secretion following lateral ventricle or third ventricle infusion of kisspeptin antagonists p-234 and p-271 35 in either ovariectomised or anestrous ewes. Central infusion of kisspeptin-10 had no effect on GH 36 secretion. To determine the level at which kisspeptin may influence GH secretion we examined 37 expression of the cognate kisspeptin receptor, GPR54, in pituitary cells and showed by 38 immunocytochemistry that the majority of somatotropes express GPR54 while expression was largely 39 negative in other pituitary cells. Overall, we have demonstrated that blocking kisspeptin signalling by 40
Introduction 44
Kisspeptin and its cognate receptor GPR54 are now well accepted as a critical component of central 45 nervous system regulation of GnRH neuron control of reproductive hormones (de Roux, et al. 2003; 46 Seminara, et al. 2003; Topaloglu, et al. 2012) . Kisspeptin neuron activity is essential for the stimulation 47
Experiment 4: Effect of lateral ventricular infusion of kisspeptin-10 on GH secretion in ovary-intact 123 anestrous ewes. 124
Experiments were performed as previously described (Li, et al. 2015) , in order to determine the role of 125 kisspeptin in mediating the LH pulses. Ovary intact ewes during the southern hemisphere anestrus season 126 (September) were prepared for LV and jugular vein cannulation (as above). Blood samples were collected 127 every 10 min for 3 h then animals received kisspeptin (40 µg/h with an initial loading dose of 40 µg, n=6) 128 or vehicle (aCSF, n=6) treatment for 4 h (200 µl/h). After the infusion, LV lines remained in place, and 129 blood sampling continued for a further 2 h (total of 9 h). Plasma was harvested immediately from samples 130 and frozen at -20 C until assayed. 131
132

GH Radioimmunoassay 133
Plasma samples from ewes were assayed in duplicate following the method of Thomas et al. (Thomas, et 134 al. 1990 ) using the standard NIDDK-oGH-I-4 and NIDDK-anti-oGH-2 antiserum. The assay sensitivity 135 was 1 ng/ml, the intra-assay CV was less than 10% between 4 and 51 ng/ml and the interassay CV was 136
20%. 137 138
Immunocytochemistry of GPR54 and pituitary hormones in ovine pituitary 139
An antiserum (RM1211) to the carboxyl terminal sequence CVLGEDNAPL of human GPR54 conjugated 140 to haemocyanin was raised in rabbits. The specificity of the highest titre antiserum was demonstrated by 141 positive membrane staining in COS7 cells transfected with the human GPR54 pcDNA and an absence of 142 staining in untransfected COS7 cells (data not shown). Pituitary glands from adult ewes were fixed in 143
Bouin's or 4% Neutral Buffered formaldehyde (4%NBF) and sections processed for 144 immunocytochemistry using GPR54 antiserum and counter stained with hematoxylin. To determine 145 which pituitary cell types expressed GPR54, dual staining was conducted with rabbit antisera raisedrehydration of sections through graded ethanols endogenous peroxidase activity was blocked using 3% 149 hydrogen peroxide in methanol, before blocking endogenous biotin using avidin/biotin block (Vector 150 labs, UK). Sections were then incubated with rabbit anti GPR54 antiserum in 20% normal goat serum in 151
Tris Buffered Saline (TBS). Binding was detected using goat anti rabbit biotinylated fab (Abcam, UK) 152
and Streptavidin-HRP before visualising with Diaminobenzidine (DAB). Following a repeat of the 153 avidin/blocking, sections were incubated with rabbit antiserum to either porcine ACTH, ovine GH, ovine 154 LH-beta or ovine prolactin at NIDDK recommended dilutions. Binding was detected using secondary 155 biotinylated fab antibody (Abcam, UK) and Streptavidin-AP before visualising with fast blue (Abcam). 156
157
Data Analysis 158
All group data are presented as the mean ± SEM. Plasma GH concentrations in response to treatment over 159 time were examined by repeated measures ANOVA. The effect of kisspeptin antagonist or kisspeptin 160 treatment on GH was further examined by comparing the mean GH concentration in samples pre-infusion 161 (0-180 min), during the infusion (Experiment 1 and 2, 180-240 min; Experiment 3, 180-720 min; 162 Experiment 4, 180-420 min) and post infusion (Experiment 1, 240-360 min; Experiment 2, 240-420 min; 163 Experiment 3, 720-1260 min; Experiment 4, 420-540 min). The mean GH values were calculated for each 164 animal during the relevant time phase and used to generate group means. Data were assessed by repeated 165 measures ANOVA. 166
Results
167
Effect of kisspeptin antagonist on GH secretion in ewes 168
Third ventricular administration of kisspeptin antagonist peptide-234 significantly increased the plasma 169 concentration of GH in OVX ewes (Figure 1a) . Mean GH was 3-fold greater during the peptide-234 170 infusion compared to aCSF control (Figure 1b, P<0.005) . Table 1 (Figure 3a) . Here, 180 the mean GH concentration over the 8 h continuous peptide-271 infusion was significantly greater than 181 during the aCSF infusion (P<0.001, Figure 3b ). From our previous analysis, the peptide-271 kisspeptin 182 antagonist in this paradigm significantly attenuated the estradiol-induced LH surge (Smith et al. 2011) . 183
184
Effect of kisspeptin-10 on GH secretion in ovary-intact anestrous ewes 185
Lateral ventricular administration of kisspeptin-10 had no effect on plasma GH concentrations in ovary-186 intact anestrous ewes (Figure 4a ). Mean GH concentration over the 4 h continuous infusion period was 187 similar between kisspeptin-10 and control ewes (Figure 4b ). In the same animals, there was a significant 188 stimulation of LH (Li et al. 2015) . 189 NBF ( Fig 5E) and Bouins (Fig 5F) Bouins fixed tissue there was little or no co-localisation of staining (<1%) in corticotropes (Fig 5A) , 198 gonadotropes ( Fig 5C) , and lactotropes (<1%, Fig 5D) , while the majority of somatotropes (86%, Fig 5B) However, Jayasena et al (Jayasena, et al. 2014 ) found no effect of kisspeptin on GH secretion from the 209 pituitary in vitro. In vivo studies present a complexity of findings including contradictory reports. High iv 210 doses (3>nmol/kg) of kisspeptin stimulated prolonged GH release in prepubertal heifers (Kadokawa et al. 211 2008) but a lower dose of kisspeptin had no effect in ovariectomised adult cows but stimulated GH when 212 progesterone or estrogen or both were administered (Whitlock et al. 2008) . Central or systemic 213 administration of kisspeptin had no effect on GH in prepubertal female pigs while inducing LH secretion 214 (Lents et al. 2008) . Similarly kisspeptin peripheral infusion had no effect on GH in cows while robustly 215 stimulating LH but preinfusion of kisspeptin reduced GH responses to GHRH and somatostatin 216 withdrawal (Whitlock et al. 2010 ). This study also reported no GH response to iv kisspeptin in ewes but a 217 small response when administered icv (Whitlock et al. 2010) . However, recently published data showkisspeptin can stimulate GH, but only in fasted ewes, by a ghrelin-NPY mediated mechanism (Foradori et 219 al. 2017 ). These complex, and often, contradictory reports may be a result of the large family of RFamide 220 receptors, which can be targeted by kisspeptin. We attempted to clarify the field by utilising specific 221 antagonists to GPR54. In our study we found no effect of administration of kisspeptin into the LV on GH 222 secretion in intact ewes, which is in agreement with the reported lack of response to peripheral 223 administration in intact cows studies (Whitlock et al. 2008 ) and prepubertal female pigs (Lents et al. 224 2008) but contrasts with a small GH increase reported in ewes (Whitlock et al. 2010 ) although the 225 immediate nutritional status may be key in this model (Foradori et al. 2017) . In women, both acute and 226 chronic peripheral administration of kisspeptin-54 failed to alter GH concentrations (Jayasena et al. 227 2014). As mentioned above, these varying and contradictory reports on the effects of kisspeptin on GH 228 may be the result of cross signalling through the large family of RFamide receptors, especially when high 229 doses are administered centrally. For example we have observed that kisspeptin has a high affinity for the 230 GnIH receptor, GPR147, while GnIH binds poorly to GPR54 (Millar RP, unpublished data) . In the same 231 study peptide-234 and peptide-271 did not bind to GPR147 suggesting that they do not interact with other 232
RFamide receptors and are better probes for determining the role of kisspeptin in GH secretion. 233
234
We have therefore attempted to reconcile these apparently conflicting effects of kisspeptin on GH by 235 administering kisspeptin antagonists in ovariectomised and estrogen treated anestrous ewes. Robust 236 increases in GH were observed in three separate and different experiments after administration of either 237 antagonist peptide-234 or antagonist peptide-271. Moreover, GH was increased regardless of site of 238 administration (3V or LV) and the nature of the antagonist: peptide-271, which has the penetratin 239 sequence attached at the NH2 terminus, designed to be cell-permeant, or non-cell-permeant peptide-234). 240
For each experiment, ovariectomy or estradiol treatment increased LH pulse and surge dynamics 241 (respectively) and kisspeptin antagonist inhibited plasma LH concentrations but had no effect on cortisol 242 or prolactin (Roseweir et al. 2009; Smith et al. 2011) . Thus, the effects are highly specific for GH increaseversus LH) appears, however, to differ, with the relatively delayed effect on LH being due to a time delay 245 in the antagonists having first to compete out endogenous kisspeptin, which then results in a decrease in 246
GnRH followed by a decrease in LH. In contrast, the effect on GH appears much more acute, possibly 247 due to the more direct and immediate effect on the pituitary somatotrope expressing GPR54 receptors. 248
249
The stimulation of GH by both kisspeptin antagonists suggests that endogenous kisspeptin is restraining 250 GH secretion in the ewe models we studied. This might be at a hypothalamic level through inhibiting 251 GHRH or stimulating somatostatin as suggested by Whitlock et al (Whitlock et al. 2010) , or directly at 252 the pituitary level on somotatropes or through other pituitary cell types that affect the somatotrope. To 253 address the site of kisspeptin action we examined the expression of GPR54 in ewe pituitary cell types 254 using a highly specific antiserum to GPR54. GPR54 was almost exclusively expressed in somatotropes 255
and was virtually absent in LH positive gonadotropes, prolactin positive lactotropes or ACTH positive 256
corticotropes. This expression of GPR54 on somatotropes therefore provides a potential mechanism for 257 the kisspeptin and antagonist effects on GH. GPR54 mRNA expression has been previously reported in 258 dispersed sheep pituitary mainly in somatotropes, with lower expression in enriched lactotropes and 259 gonadotropes (Smith, et al. 2008 ) but GPR54 protein was not examined as in this study, which showed 260 expression of protein predominantly in somatotropes. 261
262
The sources of kisspeptin, which may target GPR54 in somatotropes are potentially through hypothalamic 263 kisspeptin secretion into the portal system or from peripheral tissues via the systemic circulation or 264 through local pituitary cell production. Systemic and portal sources are unlikely because kisspeptin in 265 hypophyseal portal blood in ewes (which is the sum of hypothalamic secretion and systemic levels) is 266 very low with a maximum of 12 pg/ml (Smith et al. 2008 ). This equates to about 10 pM for Kp-10 and 2 267 pM for Kp-54. This level is too low for effective receptor occupancy as the affinity (ie 50% receptor 268 occupancy) of GPR54 for kisspeptin is about 1-5 nM (Roseweir et al. 2009 ) -about 1000 times higher.portal system or from the general circulation. Expression of kisspeptin has been reported in the pituitary 271 gland of mammalian species (Gutierrez-Pascual et al. 2007; Kotani, et al. 2001; Muir, et al. 2001; 272 Quennell, et al. 2010; Richard, et al. 2008 ) and in some instances localised to specific pituitary cell types 273 such as corticotropes in the rhesus monkey (Ramaswamy, et al. 2009 ), gonadotropes in the rat (Richard et 274 al. 2008) and to enriched somotatropes, lactotropes and gonadotropes in ewes (Smith et al. 2008 ). This 275 therefore suggests that local pituitary kisspeptin production inhibits somatotrope secretion of GH, which 276 is ablated by the antagonists to increase GH. 277
278
The demonstration in this study of a virtual absence of GPR54 in gonadotropes in the ewe indicates that 279 previous reports on kisspeptin stimulation of LH secretion from the ewe pituitary in vitro (Smith et al. 
